Filing Details

Accession Number:
0001209191-15-069828
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-08 19:14:22
Reporting Period:
2015-09-03
Filing Date:
2015-09-08
Accepted Time:
2015-09-08 19:14:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611024 D David Chang C/O Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Evp, R&D, Chief Medical Off. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-03 316 $6.89 7,220 No 4 M Direct
Common Stock Disposition 2015-09-03 316 $55.00 6,904 No 4 S Direct
Common Stock Acquisiton 2015-09-08 7,384 $6.89 14,288 No 4 M Direct
Common Stock Disposition 2015-09-08 7,384 $55.00 6,904 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-09-03 316 $0.00 316 $6.89
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-09-08 7,384 $0.00 7,384 $6.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
276,584 2024-06-05 No 4 M Direct
269,200 2024-06-05 No 4 M Direct
Footnotes
  1. Includes 904 shares acquired under the 2014 Employee Stock Purchase Plan on August 20, 2015.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2015.
  3. 25% of the 300,000 shares subject to the stock option vested and became exercisable on June 2, 2015, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.